Revenue Revenue (Tables)

12 Months Ended

Dec. 31, 2019

Revenue [Abstract]

Disaggregation of Revenue [Table Text Block]

The following table presents the approximate percentage of our net sales by market group:

	2019		2018
Biologics	25	%	21	%
Generics	20	%	21	%
Pharma	31	%	34	%
Contract-Manufactured Products	24	%	24	%
	100	%	100	%

The following table presents the approximate percentage of our net sales by product category:

	2019		2018
High-Value Components	42	%	41	%
Standard Packaging	29	%	32	%
Delivery Devices	5	%	3	%
Contract-Manufactured Products	24	%	24	%
	100	%	100	%

The following table presents the approximate percentage of our net sales by geographic location:

	2019		2018
Americas	48	%	48	%
Europe, Middle East, Africa	44	%	44	%
Asia Pacific	8	%	8	%
	100	%	100	%

Contract with Customer, Asset and Liability [Table Text Block]

The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:

	($ in millions)
Contract assets, December 31, 2018	$	9.1
Contract assets, December 31, 2019	9.8
Change in contract assets - increase (decrease)	$	0.7
Deferred income, December 31, 2018	$	(33.4)
Deferred income, December 31, 2019	(34.9)
Change in deferred income - (increase) decrease	$	(1.5)